tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

DE:1S90 Stock Latest News

Seres Therapeutics presents expanded SER-155 biomarker data at ASCO meeting
The FlySeres Therapeutics presents expanded SER-155 biomarker data at ASCO meeting
26d ago
MCRB
Buy Rating Maintained for Seres Therapeutics Amid Promising SER-155 Developments and Financial Stability
PremiumRatings
Buy Rating Maintained for Seres Therapeutics Amid Promising SER-155 Developments and Financial Stability
1M ago
MCRB
Seres Therapeutics downgraded to Neutral from Buy at Chardan
PremiumThe Fly
Seres Therapeutics downgraded to Neutral from Buy at Chardan
1M ago
MCRB
Seres Therapeutics Reports Positive Q1 2025 Results
PremiumCompany Announcements
Seres Therapeutics Reports Positive Q1 2025 Results
1M ago
MCRB
Seres Therapeutics’ Positive Earnings Call: Progress and Challenges
PremiumCompany Announcements
Seres Therapeutics’ Positive Earnings Call: Progress and Challenges
2M ago
MCRB
Seres Therapeutics Advances SER-155 Program with FDA Submission
PremiumCompany AnnouncementsSeres Therapeutics Advances SER-155 Program with FDA Submission
2M ago
8K
MCRB
Seres Therapeutics reports Q1 EPS $3.75, consensus $1.97
Premium
The Fly
Seres Therapeutics reports Q1 EPS $3.75, consensus $1.97
2M ago
MCRB
MCRB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MCRB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
MCRB
Seres Therapeutics presents three posters at DDW Conference
PremiumThe FlySeres Therapeutics presents three posters at DDW Conference
2M ago
MCRB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >